172 related articles for article (PubMed ID: 29124745)
1. Medication Access in America and Medicare Part D: Prescription Shopping Saves but May Be Costly.
Upchurch G; Disco ME; Visco JL; Huffman KF
J Am Geriatr Soc; 2018 Jan; 66(1):33-40. PubMed ID: 29124745
[TBL] [Abstract][Full Text] [Related]
2. Impacts of generic competition and benefit management practices on spending for prescription drugs: evidence from Medicare's Part D benefit.
Sheingold S; Nguyen NX
Medicare Medicaid Res Rev; 2014; 4(1):. PubMed ID: 24918023
[TBL] [Abstract][Full Text] [Related]
3. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
Cheng LI; Rascati KL
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
[TBL] [Abstract][Full Text] [Related]
4. Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis.
Li DG; Najafzadeh M; Kesselheim AS; Mostaghimi A
BMJ; 2019 Jul; 366():l4257. PubMed ID: 31315833
[TBL] [Abstract][Full Text] [Related]
5. Medicare part D after 2 years.
Joyce GF; Goldman DP; Vogt WB; Sun E; Jena AB
Am J Manag Care; 2009 Aug; 15(8):536-44. PubMed ID: 19670957
[TBL] [Abstract][Full Text] [Related]
6. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
[TBL] [Abstract][Full Text] [Related]
7. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
Raimond VC; Feldman WB; Rome BN; Kesselheim AS
Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
[TBL] [Abstract][Full Text] [Related]
8. Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act.
Myerson R; Qato DM; Goldman DP; Romley JA
JAMA; 2023 Aug; 330(7):660-662. PubMed ID: 37486673
[TBL] [Abstract][Full Text] [Related]
9. Should drug prices be negotiated under part D of Medicare? And if so, how?
Frank RG; Newhouse JP
Health Aff (Millwood); 2008; 27(1):33-43. PubMed ID: 18180478
[TBL] [Abstract][Full Text] [Related]
10. Adequacy of Prescription Drug Coverage in Long-term Care.
Briesacher B; Oliveri-Mui B; Chhabra B; Koethe B
Med Care; 2020 May; 58(5):427-432. PubMed ID: 31985585
[TBL] [Abstract][Full Text] [Related]
11. Adverse selection in the Medicare prescription drug program.
Riley GF; Levy JM; Montgomery MA
Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424
[TBL] [Abstract][Full Text] [Related]
12. The future of Medicare Part D drug plans--results from a roundtable discussion.
Balfour DC; Evans S; Januska J; Lee HY; Lewis SJ; Nolan SR; Noga M; Stemple C; Thapar K
J Manag Care Pharm; 2009; 15(1 Suppl A):18-21. PubMed ID: 19125557
[TBL] [Abstract][Full Text] [Related]
13. Improvements in Medicare Part D risk adjustment: beneficiary access and payment accuracy.
Kautter J; Ingber M; Pope GC; Freeman S
Med Care; 2012 Dec; 50(12):1102-8. PubMed ID: 22922436
[TBL] [Abstract][Full Text] [Related]
14. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.
Briesacher BA; Ross-Degnan D; Wagner AK; Fouayzi H; Zhang F; Gurwitz JH; Soumerai SB
Med Care; 2010 Jun; 48(6):503-9. PubMed ID: 20473197
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.
Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey MW; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Golub ET; Adimora AA
Med Care; 2018 Jan; 56(1):47-53. PubMed ID: 29227443
[TBL] [Abstract][Full Text] [Related]
16. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
Tseng CW; Brook RH; Keeler E; Mangione CM
JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
[TBL] [Abstract][Full Text] [Related]
17. Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.
Dusetzina SB; Conti RM; Yu NL; Bach PB
JAMA Intern Med; 2017 Aug; 177(8):1185-1188. PubMed ID: 28558108
[TBL] [Abstract][Full Text] [Related]
18. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.
Tseng CW; Dudley RA; Chen R; Walensky RP
JAMA Netw Open; 2020 Apr; 3(4):e202739. PubMed ID: 32286656
[TBL] [Abstract][Full Text] [Related]
19. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.
Yazdany J; Dudley RA; Chen R; Lin GA; Tseng CW
Arthritis Rheumatol; 2015 Jun; 67(6):1474-80. PubMed ID: 25900105
[TBL] [Abstract][Full Text] [Related]
20. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
